OXFORD-EMERGENT TUBERCULOSIS CONSORTIUM

Oxford-Emergent Tuberculosis Consortium Signs Commercial License Agreement with Vivalis to Explore Production Of MVA85A TB Vacci

 OXFORD, England, ROCKVILLE, Md., & NANTES, France–(BUSINESS WIRE)–The Oxford-Emergent Tuberculosis Consortium Ltd., a joint venture between the University of Oxford and Emergent BioSolutions Inc.

Submitted by admin on Thu, 07/23/2009 - 13:42. categories [ ]